
		October 1, 2022		July 2, 2022			December 31, 2022		July 2, 2022
ASSETS	ASSETS					ASSETS
Current assets:	Current assets:					Current assets:
Cash and cash equivalents	Cash and cash equivalents	$	2,133	$	1,707	Cash and cash equivalents	$	810	$	1,707
Trade receivables, net of allowance for doubtful accounts of $29 and $12		139,010		135,876
Trade receivables, net of allowance for doubtful accounts of $36 and $12						Trade receivables, net of allowance for doubtful accounts of $36 and $12	134,290		135,876
Contract assets	Contract assets	26,358		21,974		Contract assets	28,329		21,974
Inventories	Inventories	169,285		155,741		Inventories	171,749		155,741
Other	Other	22,803		24,710		Other	26,469		24,710
Total current assets	Total current assets	359,589		340,008		Total current assets	361,647		340,008
Property, plant and equipment, net	Property, plant and equipment, net	26,977		26,012		Property, plant and equipment, net	27,110		26,012
Operating lease right-of-use assets, net	Operating lease right-of-use assets, net	19,497		16,731		Operating lease right-of-use assets, net	18,652		16,731
Other assets:	Other assets:					Other assets:
Deferred income tax asset	Deferred income tax asset	10,770		10,055		Deferred income tax asset	10,911		10,055
Other	Other	13,131		14,117		Other	11,928		14,117
Total other assets	Total other assets	23,901		24,172		Total other assets	22,839		24,172
Total assets	Total assets	$	429,964	$	406,923	Total assets	$	430,248	$	406,923
LIABILITIES AND SHAREHOLDERS’ EQUITY	LIABILITIES AND SHAREHOLDERS’ EQUITY					LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:	Current liabilities:					Current liabilities:
Accounts payable	Accounts payable	$	134,126	$	121,393	Accounts payable	$	140,704	$	121,393
Accrued compensation and vacation	Accrued compensation and vacation	9,065		11,836		Accrued compensation and vacation	7,813		11,836
Current portion of debt, net	Current portion of debt, net	6,642		7,402		Current portion of debt, net	6,667		7,402
Other	Other	23,950		23,036		Other	18,285		23,036
Total current liabilities	Total current liabilities	173,783		163,667		Total current liabilities	173,469		163,667
Long-term liabilities:	Long-term liabilities:					Long-term liabilities:
Term loans	Term loans	5,173		5,716		Term loans	4,603		5,716
Revolving loan	Revolving loan	104,968		94,577		Revolving loan	107,204		94,577
Operating lease liabilities	Operating lease liabilities	14,128		12,023		Operating lease liabilities	13,084		12,023
Deferred income tax liability	Deferred income tax liability	21		64		Deferred income tax liability	24		64
Other long-term obligations	Other long-term obligations	5,668		5,998		Other long-term obligations	4,553		5,998
Total long-term liabilities	Total long-term liabilities	129,958		118,378		Total long-term liabilities	129,468		118,378
Total liabilities	Total liabilities	303,741		282,045		Total liabilities	302,937		282,045
Commitments and contingencies (Note 8)	Commitments and contingencies (Note 8)					Commitments and contingencies (Note 8)
Shareholders’ equity:	Shareholders’ equity:					Shareholders’ equity:
Common stock, no par value—shares authorized 25,000; issued and outstanding 10,762 and 10,762 shares, respectively	Common stock, no par value—shares authorized 25,000; issued and outstanding 10,762 and 10,762 shares, respectively	47,514		47,474		Common stock, no par value—shares authorized 25,000; issued and outstanding 10,762 and 10,762 shares, respectively	47,576		47,474
Retained earnings	Retained earnings	78,981		77,829		Retained earnings	79,948		77,829
Accumulated other comprehensive (loss)		(272)		(425)
Accumulated other comprehensive loss						Accumulated other comprehensive loss	(213)		(425)
Total shareholders’ equity	Total shareholders’ equity	126,223		124,878		Total shareholders’ equity	127,311		124,878
Total liabilities and shareholders’ equity	Total liabilities and shareholders’ equity	$	429,964	$	406,923	Total liabilities and shareholders’ equity	$	430,248	$	406,923


		Three Months Ended				Three Months Ended				Six Months Ended
		October 1, 2022		October 2, 2021				December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Net sales	Net sales	$	137,263	$	132,762		Net sales	$	123,708	$	134,456	$	260,971	$	267,218
Cost of sales	Cost of sales	126,884		122,624			Cost of sales	114,788		124,648		241,672		247,272
Gross profit	Gross profit	10,379		10,138			Gross profit	8,920		9,808		19,299		19,946
Research, development and engineering expenses	Research, development and engineering expenses	2,296		2,449			Research, development and engineering expenses	2,287		2,498		4,583		4,947
Selling, general and administrative expenses	Selling, general and administrative expenses	5,656		5,595			Selling, general and administrative expenses	5,735		5,659		11,391		11,254
Gain on insurance proceeds, net of losses	Gain on insurance proceeds, net of losses	(934)		—			Gain on insurance proceeds, net of losses	(2,710)		—		(3,644)		—
Total operating expenses	Total operating expenses	7,018		8,044			Total operating expenses	5,312		8,157		12,330		16,201
Operating income	Operating income	3,361		2,094			Operating income	3,608		1,651		6,969		3,745
Interest expense, net	Interest expense, net	1,887		992			Interest expense, net	2,507		1,095		4,394		2,087
Income before income taxes	Income before income taxes	1,474		1,102			Income before income taxes	1,101		556		2,575		1,658
Income tax provision		322		287
Income tax provision (benefit)							Income tax provision (benefit)	134		(31)		456		256
Net income	Net income	$	1,152	$	815		Net income	$	967	$	587	$	2,119	$	1,402
Net income per share — Basic	Net income per share — Basic	$	0.11	$	0.08		Net income per share — Basic	$	0.09	$	0.05	$	0.20	$	0.13
Weighted average shares outstanding — Basic	Weighted average shares outstanding — Basic	10,762		10,762			Weighted average shares outstanding — Basic	10,762		10,762		10,762		10,762
Net income per share — Diluted	Net income per share — Diluted	$	0.11	$	0.07		Net income per share — Diluted	$	0.09	$	0.05	$	0.20	$	0.13
Weighted average shares outstanding — Diluted	Weighted average shares outstanding — Diluted	10,832		11,052			Weighted average shares outstanding — Diluted	10,832		11,057		10,832		11,055


		Three Months Ended				Three Months Ended				Six Months Ended
		October 1, 2022		October 2, 2021				December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Comprehensive income:	Comprehensive income:						Comprehensive income:
Net income	Net income	$	1,152	$	815		Net income	$	967	$	587	$	2,119	$	1,402
Other comprehensive income (loss):	Other comprehensive income (loss):						Other comprehensive income (loss):
Unrealized gain (loss) on hedging instruments, net of tax	Unrealized gain (loss) on hedging instruments, net of tax	153		(1,531)			Unrealized gain (loss) on hedging instruments, net of tax	59		(1,084)		212		(2,615)
Comprehensive income		$	1,305	$	(716)
Comprehensive income (loss)							Comprehensive income (loss)	$	1,026	$	(497)	$	2,331	$	(1,213)

Other comprehensive income (loss) for the three months ended ~~October 2, 2021,~~December 31, 2022 and January 1, 2022, is reflected net of tax expense (benefit) of approximately ~~$(0.3) million.~~$0.0 million and $(0.5) million, respectively. Other comprehensive income (loss) for the six months ended December 31, 2022 and January 1, 2022, is reflected net of tax expense (benefit) of approximately $0.0 million and $(0.8) million, respectively.


		Three Months Ended					Six Months Ended
		October 1, 2022		October 2, 2021			December 31, 2022		January 1, 2022
Operating activities:	Operating activities:					Operating activities:
Net income	Net income	$	1,152	$	815	Net income	$	2,119	$	1,402
Adjustments to reconcile net income to cash used in operating activities:	Adjustments to reconcile net income to cash used in operating activities:					Adjustments to reconcile net income to cash used in operating activities:
Depreciation and amortization	Depreciation and amortization	2,385		1,335		Depreciation and amortization	4,658		2,613
Amortization of interest rate swap	Amortization of interest rate swap	153		75		Amortization of interest rate swap	211		151
Amortization of deferred loan costs	Amortization of deferred loan costs	37		32		Amortization of deferred loan costs	51		69
Provision for warranty	Provision for warranty	152		75		Provision for warranty	266		228
Provision for doubtful accounts	Provision for doubtful accounts	14		26		Provision for doubtful accounts	22		54
Gain on disposal of assets	Gain on disposal of assets	(123)		—		Gain on disposal of assets	(123)		—
Gain on insurance proceeds, net of losses	Gain on insurance proceeds, net of losses	(934)		—		Gain on insurance proceeds, net of losses	(3,644)		—
Share-based compensation expense	Share-based compensation expense	40		68		Share-based compensation expense	102		143
Deferred income taxes	Deferred income taxes	(344)		(220)		Deferred income taxes	(120)		(175)
Changes in operating assets and liabilities:	Changes in operating assets and liabilities:					Changes in operating assets and liabilities:
Trade receivables	Trade receivables	(1,776)		(16,155)		Trade receivables	1,564		(13,143)
Contract assets	Contract assets	(4,384)		1,130		Contract assets	(6,355)		(1,187)
Inventories	Inventories	(13,544)		(5,802)		Inventories	(16,007)		(20,421)
Other assets	Other assets	3,601		(7,092)		Other assets	2,478		(13,537)
Accounts payable	Accounts payable	12,732		18,835		Accounts payable	19,310		39,019
Accrued compensation and vacation	Accrued compensation and vacation	(2,771)		(2,995)		Accrued compensation and vacation	(4,023)		(4,114)
Other liabilities	Other liabilities	(2,227)		(4,753)		Other liabilities	(10,540)		(1,630)
Cash used in operating activities	Cash used in operating activities	(5,837)		(14,626)		Cash used in operating activities	(10,031)		(10,528)
Investing activities:	Investing activities:					Investing activities:
Purchase of property and equipment	Purchase of property and equipment	(2,526)		(1,791)		Purchase of property and equipment	(3,859)		(2,766)

Proceeds from sale of fixed assets						Proceeds from sale of fixed assets	—		2
Proceeds from insurance						Proceeds from insurance	3,500		—
Cash used in investing activities	Cash used in investing activities	(2,526)		(1,791)		Cash used in investing activities	(359)		(2,764)
Financing activities:	Financing activities:					Financing activities:
Payment of financing costs	Payment of financing costs	—		(80)		Payment of financing costs	—		(118)
Proceeds from issuance of long term debt	Proceeds from issuance of long term debt	—		5,055		Proceeds from issuance of long term debt	—		7,004
Repayments of long term debt	Repayments of long term debt	(543)		(532)		Repayments of long term debt	(1,089)		(1,066)
Borrowings on revolver, net	Borrowings on revolver, net	10,354		10,446		Borrowings on revolver, net	12,552		6,122
Principal payments on finance leases	Principal payments on finance leases	(1,022)		(401)		Principal payments on finance leases	(1,970)		(1,077)
Cash provided by financing activities	Cash provided by financing activities	8,789		14,488		Cash provided by financing activities	9,493		10,865
Net increase (decrease) in cash and cash equivalents		426		(1,929)
Net decrease in cash and cash equivalents						Net decrease in cash and cash equivalents	(897)		(2,427)
Cash and cash equivalents, beginning of period	Cash and cash equivalents, beginning of period	1,707		3,473		Cash and cash equivalents, beginning of period	1,707		3,473
Cash and cash equivalents, end of period	Cash and cash equivalents, end of period	$	2,133	$	1,544	Cash and cash equivalents, end of period	$	810	$	1,046

Supplemental cash flow information:	Supplemental cash flow information:					Supplemental cash flow information:
Interest payments	Interest payments	$	1,894	$	999	Interest payments	$	3,712	$	1,811
Income tax payments, net of refunds	Income tax payments, net of refunds	$	414	$	210	Income tax payments, net of refunds	$	776	$	530
Recognition of operating lease liabilities and right-of-use assets	Recognition of operating lease liabilities and right-of-use assets	$	4,613	$	4,695	Recognition of operating lease liabilities and right-of-use assets	$	5,049	$	5,246
Recognition of financing lease liabilities and right-of-use assets	Recognition of financing lease liabilities and right-of-use assets	$	—	$	4,456	Recognition of financing lease liabilities and right-of-use assets	$	—	$	5,973


		Three Months Ended				Three Months Ended				Six Months Ended
		October 1, 2022		October 2, 2021				December 31, 2022		January 1, 2022		December 31, 2022		January 1, 2022
Total shareholders’ equity, beginning balances	Total shareholders’ equity, beginning balances	$	124,878	$	123,705		Total shareholders’ equity, beginning balances	$	126,223	$	123,705	$	124,878	$	123,705

Common stock (shares):	Common stock (shares):						Common stock (shares):
Beginning balances	Beginning balances	10,762		10,762			Beginning balances	10,762		10,762		10,762		10,762
Exercise of stock appreciation rights	Exercise of stock appreciation rights	—		—			Exercise of stock appreciation rights	—		—		—		—
Ending balances	Ending balances	10,762		10,762			Ending balances	10,762		10,762		10,762		10,762

Common stock:	Common stock:						Common stock:
Beginning balances	Beginning balances	$	47,474	$	47,181		Beginning balances	$	47,514	$	47,249	47,475		$	47,181
Share-based compensation	Share-based compensation	40		68			Share-based compensation	62		75		101		143
Exercise of stock options	Exercise of stock options	—		—			Exercise of stock options	—		—		—		—
Ending balances	Ending balances	47,514		47,249			Ending balances	47,576		47,324		47,576		47,324

Retained Earnings:	Retained Earnings:						Retained Earnings:
Beginning balances	Beginning balances	$	77,829	$	74,452		Beginning balances	$	78,981	$	75,267	$	77,829	$	74,452
Net income	Net income	1,152		815			Net income	967		587		2,119		1,402
Ending balances	Ending balances	78,981		75,267			Ending balances	79,948		75,854		79,948		75,854

Accumulated other comprehensive income (loss):	Accumulated other comprehensive income (loss):						Accumulated other comprehensive income (loss):
Beginning balances	Beginning balances	$	(425)	$	2,072		Beginning balances	$	(272)	$	541	$	(425)	$	2,072
Unrealized gain (loss) on hedging instruments, net	Unrealized gain (loss) on hedging instruments, net	153		(1,531)			Unrealized gain (loss) on hedging instruments, net	59		(1,084)		212		(2,615)
Ending balances	Ending balances	(272)		541			Ending balances	(213)		(543)		(213)		(543)
Total shareholders’ equity, ending balances	Total shareholders’ equity, ending balances	$	126,223	$	123,057		Total shareholders’ equity, ending balances	$	127,311	$	122,635	$	127,311	$	122,635

The consolidated financial statements included herein have been prepared by Key Tronic Corporation and subsidiaries (the Company) pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosures normally included in our annual consolidated financial statements have been condensed or omitted. The year-end condensed consolidated balance sheet information was derived from audited financial statements, but does not include all disclosures required by accounting principles generally accepted in the United States of America. The financial statements reflect all normal and recurring adjustments which, in the opinion of management, are necessary for a fair presentation of the financial position, results of operations and cash flows for the interim periods presented. The preparation of financial statements in accordance with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. The results of operations for the periods presented are not necessarily indicative of the results to be expected for the full year. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended July 2, 2022.

The Company’s reporting period is a 52/53 week fiscal year ending on the Saturday closest to June 30. The three month and six month periods ended ~~October~~December 31, 2022 and January 1, 2022, ~~and October 2, 2021,~~ were both 13 week periods. Fiscal year 2023 will end on July 1, 2023, which is a 52 week year. Fiscal year 2022 which ended on July 2, 2022, was also a 52 week year.

Due to the COVID-19 pandemic, the Company has seen extreme shifts in demand from its customer base, and shifts in supply chain and logistics risks. The possibility of future temporary closures, as well as adverse fluctuations in customer demand, freight and expedite costs, precautionary safety expenses and labor shortages, collectability of accounts, and future supply chain disruptions during the rapidly changing COVID-19 environment can materially impact operating results. Additionally, continued adverse macroeconomic conditions and significant currency exchange fluctuations can also materially impact operating results.

Basic earnings per common share (EPS) is computed by dividing net income (loss) by the weighted average number of common shares outstanding during the period. Diluted EPS is computed by dividing net income (loss) by the combination of other potentially dilutive weighted average common shares and the weighted average number of common shares outstanding during the period using the treasury stock method. The computation assumes the proceeds from the exercise of equity awards were used to repurchase common shares at the average market price during the period. The computation of diluted EPS does not assume conversion, exercise, or contingent issuance of common stock equivalent shares that would have an anti-dilutive effect on EPS.

The Company has entered into foreign currency forward contracts that are accounted for as cash flow hedges. The effective portion of the gain or loss on the derivative is reported as a component of accumulated other comprehensive income (AOCI) and is reclassified into earnings in the same period in which the underlying hedged transaction affects earnings. The derivative’s effectiveness represents the change in fair value of the hedge that offsets the change in fair value of the hedged item.

The Company’s foreign currency forward contracts potentially expose the Company to credit risk to the extent the counterparty may be unable to meet the terms of the agreement. The Company minimizes such risk by utilizing a counterparty with a strong credit rating. The Company’s counterparty to the foreign currency forward contracts is a major banking institution. This institution does not require collateral for the contracts, and the Company believes that the risk of the counterparty failing to meet their contractual obligations is remote. The Company does not enter into derivative instruments for trading or speculative purposes.

We compute our interim income tax provision through the use of an estimated annual effective tax rate (ETR) applied to year-to-date operating results and specific events that are discretely recognized as they occur. In determining the estimated annual ETR, we analyze various factors, including projections of our annual earnings, taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, our ability to use tax credits and available tax planning alternatives. Discrete items, including the effect of changes in tax laws, tax rates, and certain circumstances with respect to valuation allowances or other unusual or non-recurring tax adjustments, are reflected in the period in which they occur as an addition to, or reduction from, the income tax provision, rather than included in the estimated annual ETR.

Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the estimated future tax consequences and benefits attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases, as well as tax credit and net operating loss carryforwards. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which temporary differences and carryforwards are expected to be recovered or settled. The effect on deferred tax assets and liabilities for a change in tax rates is recognized in the period that includes the enactment date. Valuation allowances are established when necessary to reduce deferred tax assets to the amount that is more likely than not to be realized.

We utilize a two-step approach to recognizing and measuring uncertain tax positions. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount which is more than 50% likely of being realized upon ultimate settlement. We consider many factors when evaluating and estimating our tax positions and tax benefits, which may require periodic adjustments based on new assessments and changes in estimates and which may not accurately forecast actual outcomes. Our policy is to recognize interest and penalties related to the underpayment of income taxes as a component of income tax expense. The tax years 2001 through the present remain open to examination by the major U.S. taxing jurisdictions to which we are subject. Refer to Note 5 for further discussions.

In January 2021, the Financial Accounting Standards Board (FASB) issued Accounting Standard Update (ASU) 2021-01, Reference Rate Reform (Topic 848) to identify alternative reference rates that are more observable or transaction based and less susceptible to manipulation. The Company is currently assessing the effects on its consolidated financial statements, and if it will elect this optional standard.

In March of 2020, the FASB issued ASU 2020-03, Codification Improvements to Financial Instruments, which clarifies specific issues raised by stakeholders. Specifically, the ASU clarifies the following: 1) that all entities are required to provide the fair value option disclosures in ASC 825, Financial Instruments 2) clarifies that the portfolio exception in ASC 820, Fair Value Measurement, applies to nonfinancial items accounted for as derivatives under ASC 815, Derivatives and Hedging; 3) clarifies that for purposes of measuring expected credit losses on a net investment in a lease in accordance with ASC 326, Financial Instruments - Credit Losses, the lease term determined in accordance with ASC 842, Leases, should be used as the contractual term; 4) clarifies that when an entity regains control of financial assets sold, it should recognize an allowance for credit losses in accordance with ASC 326; and 5) aligns the disclosure requirements for debt securities in ASC 320, Investments - Debt Securities, with the corresponding requirements for depository and lending institutions in ASC 942, Financial Services - Depository and Lending. The amendments in the ASU have various effective dates and transition requirements which are dependent on timing of adoption of ASU 2016-13. The Company is currently assessing the effects on its consolidated financial statements, and it intends to adopt the guidance as they become effective.

In June 2016, the FASB issued ASU 2016-13 “Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments” and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04 and ASU 2019-05, which replaces the existing incurred loss impairment model with an expected credit loss model and requires a financial asset measured at amortized cost to be presented at the net amount expected to be collected. The guidance is effective for the Company beginning in the first quarter of fiscal year 2024 with early adoption permitted. The Company is currently assessing the impact on its consolidated financial statements, and it intends to adopt the guidance when it becomes effective in the first quarter of fiscal year 2024.

On September 3, 2021, the Company entered into an amendment to the Company’s current loan agreement with Bank of America. The amendment increases the Company’s current credit facility of $93 million to $120 million, subject to the Company’s borrowing base, maturing on September 3, 2026. As of ~~October 1,~~December 31, 2022, the Company had an outstanding balance under the asset-based revolving credit facility of ~~$105.4~~$107.6 million, $0.3 million in outstanding letters of credit and ~~$10.6~~$1.8 million available for future borrowings.

Generally, the interest rate applicable to loans under the Bank of America loan agreement will be, at the Company’s option: (i)(A) the base rate which is the highest of (1) the prime rate for the applicable day (as such rate is determined from time to time by the Bank), (2) the federal funds rate for the applicable day plus 0.50%, and (3) LIBOR for a 30-day interest period as of the applicable day plus 1.00% (provided that in no event shall the base rate be less than zero), plus the applicable interest margin for base rate loans; and (B) LIBOR rate for an applicable interest period (provided that in no event shall the LIBOR rate be less than 0.50%), plus the applicable interest margin for LIBOR rate loans. Depending on average daily excess borrowing availability over applicable periods under the Credit Facility, applicable interest margins on: (x) base rate loans will be 1.25-1.75%; and (y) LIBOR rate loans will be 2.25-2.75%, resetting on a quarterly basis beginning in early 2021. If there is an event of default under the loan agreement, all loans and other obligations will bear interest at a rate of an additional 2.00% on the otherwise applicable interest rates. In addition to interest charges, the Company is required to pay a fee of 0.25% per annum on the unused portion of the Credit Facility, monthly in arrears.

On August 14, 2020, the Company also entered into a $5.0 million equipment financing facility relating to the Company’s existing U.S. manufacturing equipment that bears interest at 4.85% and matures on August 14, 2025. Under this loan agreement, equal monthly payments of approximately $94,000 commenced on September 14, 2020 and will continue through the maturity of the equipment financing facility on August 14, 2025. As of ~~October 1,~~December 31, 2022, the Company had an outstanding balance of ~~$3.1~~$2.8 million. As of July 2, 2022, the Company had an outstanding balance of $3.3 million under the Bank of America equipment term loan agreement.

On November 24, 2020, the Company entered into a $6.0 million equipment financing facility related to the Company’s existing manufacturing equipment that bears interest at 5.52% and matures on April 24, 2026. Under this loan agreement, equal monthly payments of $100,000 commenced on May 24, 2021 and will continue through the maturity of the equipment financing facility on April 24, 2026. As of ~~October 1,~~December 31, 2022, the Company had an outstanding balance of ~~$4.3~~$4.0 million. As of July 2, 2022, the Company had an outstanding balance of $4.6 million.


Fiscal Years Ending	Fiscal Years Ending	Amount		Fiscal Years Ending	Amount
2023 (1)	2023 (1)	$	1,647	2023 (1)	$	1,101
2024	2024	2,239		2024	2,239
2025	2025	2,290		2025	2,290
2026	2026	1,187		2026	1,187
2027	2027	105,430		2027	110,130
Thereafter	Thereafter	—		Thereafter	—
Total debt	Total debt	$	112,793	Total debt	$	116,947
Unamortized debt issuance costs	Unamortized debt issuance costs	(462)		Unamortized debt issuance costs	(425)
Long-term debt, net of debt issuance costs	Long-term debt, net of debt issuance costs	$	112,331	Long-term debt, net of debt issuance costs	$	116,522

The Company expects to repatriate a portion of its foreign earnings based on increased net sales growth driving additional capital requirements domestically, cash requirements for potential acquisitions and to implement certain tax strategies. The Company currently expects to repatriate approximately ~~$8.6~~$8.1 million of foreign earnings in the future. All other unremitted foreign earnings are expected to remain permanently reinvested for planned fixed assets purchases and improvements in foreign locations.

Repatriations of cash will generally be tax-free in the U.S. However, withholding taxes in China may still apply to any such future repatriations. Management has not changed its indefinite investment assertions with regard to the portion of accumulated earnings and profits in China that may be repatriated in the future. Accordingly, management estimates that future repatriations of cash from China may result in approximately $0.8 million of withholding tax. We do not anticipate there would be any offsetting foreign tax credits in the U.S. and as such, this potential liability is a direct cost associated with actual repatriations. Withholding taxes would not apply to future repatriations from Mexico or Vietnam.

The Company has available approximately ~~$10.6~~$10.8 million of gross federal research and development tax credits as of ~~October 1,~~December 31, 2022. ASC 740 requires the Company to recognize in its financial statements uncertainties in tax positions taken that may not be sustained upon examination by the taxing authorities. Accordingly, as of ~~October 1,~~December 31, 2022, the Company has recorded $3.1 million of unrecognized tax benefits associated with these federal tax credits, resulting in a net deferred tax benefit of approximately ~~$7.5~~$7.7 million.

The Company evaluated tax law changes and regulatory guidance issued through the prior fiscal year. Such changes and regulations include guidance under Sec. 162(m), Sec. 245A, Sec. 951A, foreign tax credits, and rules relating to consolidated NOL carryback claims. The Company evaluated the ongoing impact of these law and regulatory changes, which did not have a material impact on its provision for income taxes. On August 16, 2022, the Inflation Reduction Act of 2022 was signed into law. The Inflation Reduction Act of 2022 includes a new book minimum tax on certain large corporations and an excise tax on corporate stock buybacks, among other provisions. The Company is evaluating the impacts of this act, and at this time the Company does not believe they will have a material impact on our consolidated financial position, results of operations, or cash flows.

On January 27, 2021, the Company received official notice from the Vietnamese tax authorities, confirming tax benefits awarded (the “Tax Holiday”) related to the Company’s principal product line in Vietnam. The tax rate related to this product line will be zero percent for four years beginning with fiscal year 2021, then five percent for nine years, then ten percent for one year (as opposed to the normal twenty percent each year). Consequently, Management determined that the net operating loss in Vietnam more likely than not would result in minimal, if any, tax benefit, and the Company recorded a valuation allowance against the entire Vietnam net operating loss deferred tax asset ($0.2 million) in the third quarter of fiscal year 2021.


		Three Months Ended					Three Months Ended
		(in thousands, except share and per share information)					(in thousands, except share and per share information)
		October 1, 2022		October 2, 2021			December 31, 2022		January 1, 2022
Net income	Net income	$	1,152	$	815	Net income	$	967	$	587
Weighted average shares outstanding—basic	Weighted average shares outstanding—basic	10,762		10,762		Weighted average shares outstanding—basic	10,762		10,762
Effect of dilutive common stock awards	Effect of dilutive common stock awards	70		290		Effect of dilutive common stock awards	70		295
Weighted average shares outstanding—diluted	Weighted average shares outstanding—diluted	10,832		11,052		Weighted average shares outstanding—diluted	10,832		11,057
Net income per share—basic	Net income per share—basic	$	0.11	$	0.08	Net income per share—basic	$	0.09	$	0.05
Net income per share—diluted	Net income per share—diluted	$	0.11	$	0.07	Net income per share—diluted	$	0.09	$	0.05
Antidilutive SARs not included in diluted earnings per share	Antidilutive SARs not included in diluted earnings per share	904		629		Antidilutive SARs not included in diluted earnings per share	904		629


	Six Months Ended
	(in thousands, except per share information)
	December 31, 2022		January 1, 2022
Net income	$	2,119	$	1,402
Weighted average shares outstanding—basic	10,762		10,762
Effect of dilutive common stock awards	70		293
Weighted average shares outstanding—diluted	10,832		11,055
Net income per share—basic	$	0.20	$	0.13
Net income per share—diluted	$	0.20	$	0.13
Antidilutive SARs not included in diluted earnings per share	904		619

The Company’s incentive plan provides for equity and liability awards to employees and non-employee directors in the form of stock options, stock appreciation rights (SARs), restricted stock, restricted stock units, stock awards, stock units, performance shares, performance units, and other stock-based or cash-based awards. Compensation cost is recognized on a straight-line basis over the requisite employee service period, which is generally the vesting period, and is recorded as employee compensation expense in cost of goods sold, research, development and engineering, and selling, general and administrative expenses. Share-based compensation is recognized only for those awards that are expected to vest, with forfeitures estimated at the date of grant based on historical experience and future expectations.

In addition to service conditions, SARs contain a performance condition. The additional performance condition is based upon the achievement of Return on Invested Capital (ROIC) goals relative to a peer group. All awards with performance conditions are evaluated quarterly to determine the likelihood that performance metrics will be achieved during the performance period. These awards are charged to compensation expense over the requisite service period based on the number of shares expected to vest. The SARs cliff vest after a three-year period from date of grant and expire five years from date of grant.

Total share-based compensation expense recognized during the three months ended ~~October~~December 31, 2022 and January 1, 2022 ~~and October 2, 2021~~ was approximately ~~$40,000~~$62,000 and ~~$68,000,~~$75,000, respectively. Total share-based compensation expense recognized during the six months ended December 31, 2022 and January 1, 2022 was approximately $102,000 and $143,000, respectively.

As of ~~October 1,~~December 31, 2022, total unrecognized compensation expense related to unvested share-based compensation arrangements was approximately ~~$0.6~~$0.5 million. This expense is expected to be recognized over a weighted average period of ~~2.16~~1.96 years. No SARs were exercised during the three or six months ended ~~October 1,~~December 31, 2022 or ~~October 2, 2021.~~January 1, 2022.

The Company provides warranties on certain product sales. Allowances for estimated warranty costs are recorded during the period of sale. The determination of such allowances requires the Company to make estimates of product return rates and expected costs to repair or to replace the products under warranty. If actual return rates and/or repair and replacement costs differ significantly from management’s estimates, adjustments to recognize additional cost of sales may be required in future periods. The Company’s warranty reserve was approximately ~~$30,000~~$83,000 as of ~~October 1,~~December 31, 2022 and $31,000 as of July 2, 2022, respectively.

Gain from insurance recoveries, net of losses, relate to losses incurred from storm damage to the Company’s Arkansas facility on July 29, 2022, as the result of a lightning strike. During the three and six months ended ~~October 1,~~December 31, 2022, the Company recorded a gain from insurance recoveries, net of losses, of ~~$0.9~~$2.7 million and $3.6 million, respectively due to the storm ~~event. The gain is~~event.The gains are net of a $0.4 million loss on the disposal of fixed assets, which were damaged in the event.

~~Subsequent to~~During the ~~end of the first~~second quarter of fiscal year 2023, the Company received ~~initial~~additional insurance proceeds of $1$3.5 million to repair the plant and replace equipment, which should be completed by the second half of fiscal year 2023. These initial coverage amounts, net of equipment book value loss, are included in reported gain on insurance claims during the quarter.

As of ~~October 1,~~December 31, 2022, the Company did not have any outstanding foreign currency forward contracts. For the three months ended ~~October 1,~~December 31, 2022, the Company did not enter into or settle any foreign currency forward contracts. During the same period of the previous year, the Company did not enter into any foreign currency forward contracts and settled $5.1 million of contracts.

On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of September 30, 2022, related to the borrowings outstanding under the term loan with Wells Fargo Bank. This interest rate swap contract was terminated on August 14, 2020 when the Company entered into a loan and security agreement with Bank of America. On the date of termination this interest rate swap was in a liability position of $148,400, which ~~will be~~has been amortized to interest expense over the original term of the swap.

On November 6, 2019, the Company entered into an interest rate swap contract with an effective date of November 6, 2019 and a termination date of November 1, 2023, related to the borrowings outstanding under the line of credit with Wells Fargo Bank. This interest rate swap contract was terminated on August 14, 2020 when the Company entered into a loan and security agreement with Bank of America. On the date of termination this interest rate swap was in a liability position of $776,500, which will be amortized to interest expense over the original term of the swap.


Derivatives Designated as Hedging Instruments	Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of July 2, 2022		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of October 1, 2022		Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of October 1, 2022		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of December 31, 2022
Forward contracts	Forward contracts	Cost of sales	$	(79)	$	—	$	79	$	—	Forward contracts	Cost of sales	$	—	$	—	$	—	$	—
Interest rate swap	Interest rate swap	Interest expense	(346)		—		74		(272)		Interest rate swap	Interest expense	(272)		—		59		(213)
Total	Total		$	(425)	$	—	$	153	$	(272)	Total		$	(272)	$	—	$	59	$	(213)

Derivatives Designated as Hedging Instruments	Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of July 3, 2021		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of October 2, 2021		Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of October 2, 2021		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of January 1, 2022
Forward contracts	Forward contracts	Cost of sales	$	2,721	$	224	$	(1,830)	$	1,115	Forward contracts	Cost of sales	$	1,115	$	338	$	(1,498)	$	(45)
Interest rate swap	Interest rate swap	Interest expense	(649)		—		75		(574)		Interest rate swap	Interest expense	(574)		—		76		(498)
Total	Total		$	2,072	$	224	$	(1,755)	$	541	Total		$	541	$	338	$	(1,422)	$	(543)


Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of July 2, 2022		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of December 31, 2022
Forward contracts	Cost of sales	$	(79)	$	—	$	79	$	—
Interest rate swap	Interest expense	(346)		—		133		(213)
Total		$	(425)	$	—	$	212	$	(213)

Derivatives Designated as Hedging Instruments	Classification of Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion)	AOCI Balance as of July 3, 2021		Effective Portion Recorded In AOCI		Effective Portion Reclassified From AOCI Into Income		AOCI Balance as of January 1, 2022
Forward contracts	Cost of sales	$	2,721	$	562	$	(3,328)	$	(45)
Interest rate swap	Interest expense	(649)		—		151		(498)
Total		$	2,072	$	562	$	(3,177)	$	(543)

As of ~~October 1,~~December 31, 2022, the Company does not have any foreign exchange contracts with credit-risk-related contingent features. The Company is subject to the risk of fluctuating interest rates from our line of credit and foreign currency risk resulting from our China operations. The Company does not currently manage these risk exposures by using derivative instruments.

The Company specializes in services ranging from product manufacturing to engineering and tooling services. The first step in its process for revenue recognition is to identify the contract with a customer. A contract is defined as an agreement between two or more parties that creates enforceable rights and obligations. A contract can be written, oral, or implied. The Company generally enters into manufacturing service agreements (“MSA”) with its customers that outline the terms of the business relationship between the customer and the Company. This includes matters such as warranty, indemnification, transfer of title and risk of loss, liability for excess and obsolete inventory, pricing, payment terms, etc. The Company will also bid on a program-by-program basis for customers in which an executed MSA may not be in place. In these instances, as well as when we have an MSA in place, we receive customer purchase orders for specific quantities and timing of products. As a result, the

The Company assesses whether control of the product or services promised under the contract is transferred to the customer at a point in time (shipment) or over time (as we manufacture the product). The Company is first required to evaluate whether its contracts meet the criteria for 'over-time' or 'point-in-time' recognition. The Company has determined that for the majority of its contracts the Company is manufacturing products for which there is no alternative use due to the unique nature of the customer-specific product, IP and other contract restrictions. The Company has an enforceable right to payment including a reasonable profit for performance completed to date with respect to these contracts. As a result, revenue is recognized under these contracts 'over-time' based on the input cost-to-cost method as it better depicts the transfer of control. This input method is based on the ratio of costs incurred to date as compared to the total estimated costs at completion of the performance obligation. For all other contracts that do not meet these criteria, such as manufacturing contracts for which the terms do not provide an enforceable right to payment for performance completed to date, the Company recognizes revenue when it has transferred control of the related manufactured products which generally occurs upon shipment to the customer. Revenue from engineering services is recognized over time as the services are performed.

The Company generally provides a warranty for workmanship on its manufacturing contracts. Although we offer warranties on our products, our warranties are considered to be assurance-type in nature and do not cover anything beyond ensuring that the product is functioning as intended. Based on the guidance in ASC 606, assurance-type warranties do not represent separate performance obligations; therefore, the primary performance obligation in the majority of our contracts is the delivery of a specific good through the purchase order submitted by our customer.

A contract asset is recognized when the Company has recognized revenue, but has not issued an invoice for payment. Contract assets are classified separately on the condensed consolidated balance sheet and transferred to receivables when the right to payment becomes unconditional. The following table summarizes the activity in the Company’s contract assets during the ~~three~~six months ended ~~October 1,~~December 31, 2022 (in thousands):


									Three Months Ended						Six Months Ended
									December 31, 2022		January 1, 2022				December 31, 2022				January 1, 2022
Lease cost	Lease cost	Classification	October 1, 2022		October 2, 2021		Lease cost	Classification
Operating lease cost	Operating lease cost	Cost of sales	$	1,334	$	1,433	Operating lease cost	Cost of sales	$	2,441			$	1,598			$	3,775			$	3,031
Operating lease cost	Operating lease cost	Selling, general and administrative expenses	$	184	$	308	Operating lease cost	Selling, general and administrative expenses	$	367	$	250			$	551			$	558

Financing lease cost	Financing lease cost	Cost of sales	$	900	$	434	Financing lease cost	Cost of sales	$	1,859	$	617			$	2,759			$	1,051
Financing lease cost	Financing lease cost	Selling, general and administrative expenses	$	38	$	10	Financing lease cost	Selling, general and administrative expenses	$	77	$	17			$	115			$	27

Total lease cost	Total lease cost		$	2,456	$	2,185	Total lease cost		$	4,744	$	2,482			$	7,200			$	4,667

Fixed lease cost	Fixed lease cost		$	2,221	$	1,777	Fixed lease cost		$	4,435	$	2,081			$	6,656			$	3,858
Short-term lease cost	Short-term lease cost		$	235	$	408	Short-term lease cost		$	309	$	401			$	544			$	809
Total lease cost	Total lease cost		$	2,456	$	2,185	Total lease cost		$	4,744	$	2,482			$	7,200			$	4,667


	~~October 1, 2022~~
~~Operating Leases:~~
~~Operating lease right of use assets~~	$	~~19,497~~
~~Operating lease liabilities~~ ~~(1)~~	$	~~19,497~~

~~Weighted-average remaining lease term (in years)~~
~~Operating leases~~	~~5.08~~

~~Weighted-average discount rate~~
~~Operating leases~~	~~4.0~~		%

~~Financing Leases~~ ~~(2)~~:
~~Financing lease right of use assets~~	$	~~11,373~~
~~Financing lease liabilities~~	$	~~10,120~~

~~Weighted-average remaining lease term (in years)~~
~~Financing leases~~	~~2.31~~

~~Weighted-average discount rate~~
~~Financing leases~~	~~8.8~~		%


	December 31, 2022			July 2, 2022
Operating Leases:
Operating lease right of use assets	$	18,652		$	16,731
Operating lease liabilities (1)	$	18,652		$	16,731

Weighted-average remaining lease term (in years)
Operating leases	4.84			5.28

Weighted-average discount rate
Operating leases	4.0		%	4.0		%

Financing Leases (2):
Financing lease right of use assets	$	10,258		$	12,464
Financing lease liabilities	$	9,006		$	11,211

Weighted-average remaining lease term (in years)
Financing leases	2.08			2.56

Weighted-average discount rate
Financing leases	8.8		%	8.8		%


		Three Months Ended					Six Months Ended
		October 1, 2022		October 2, 2021			December 31, 2022		January 1, 2022
Cash paid for amounts included in the measurement of lease liabilities:	Cash paid for amounts included in the measurement of lease liabilities:					Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows from operating leases	Operating cash flows from operating leases	$	1,847	$	1,446	Operating cash flows from operating leases	$	3,128	$	1,924
Financing cash flows used in financing leases	Financing cash flows used in financing leases	$	1,022	$	401	Financing cash flows used in financing leases	$	1,970	$	1,077


Fiscal Years Ending	Fiscal Years Ending	Operating Leases		Finance Leases		Fiscal Years Ending	Operating Leases		Finance Leases
2023 (1)	2023 (1)	$	4,125	$	3,910	2023 (1)	$	2,877	$	2,607
2024	2024	4,826		3,960		2024	5,048		3,960
2025	2025	3,987		2,539		2025	3,987		2,539
2026	2026	3,365		107		2026	3,365		107
2027	2027	2,464		71		2027	2,464		71
Thereafter	Thereafter	3,240		—		Thereafter	3,240		—
Total undiscounted lease payments	Total undiscounted lease payments	22,007		10,587		Total undiscounted lease payments	20,981		9,284
Less: present value discount	Less: present value discount	(2,510)		(467)		Less: present value discount	(2,329)		(278)
Total lease liabilities	Total lease liabilities	$	19,497	$	10,120	Total lease liabilities	$	18,652	$	9,006

This Quarterly Report contains forward-looking statements in addition to historical information. Forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those reflected in the forward-looking statements. Risks and uncertainties that might cause such differences include, but are not limited to those outlined in “Management’s Discussion and Analysis of Financial Condition and Results of Operations—Risks and Uncertainties that May Affect Future Results.” Readers are cautioned not to place undue reliance on forward-looking statements, which reflect management’s opinions only as of the date hereof. The Company undertakes no obligation to update forward-looking statements to reflect developments or information obtained after the date hereof and disclaims any obligation to do so. Readers should carefully review the risk factors described in this report and other periodic reports the Company files from time to time with the Securities and Exchange Commission, including Annual Reports on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K.

Key Tronic is a leading contract manufacturer offering value-added design and manufacturing services from its facilities in the United States, Mexico, China, and Vietnam. The Company provides its customers full engineering services, materials management, worldwide manufacturing facilities, assembly services, in-house testing, and worldwide distribution. Its customers include some of the world’s leading original equipment manufacturers. Our combined capabilities and vertical integration are proving to be a desirable offering to our expanded customer base.

Our international production capability provides our customers with benefits of improved supply-chain management, reduced inventories, lower transportation costs, and reduced product fulfillment time. We continue to make investments in all of our operating facilities to give us the production capacity, capabilities, and logistical advantages to continue to win new business. The following information should be read in conjunction with the consolidated financial statements included herein and with Part II Item 1A, Risk Factors included as part of this filing.

For the ~~first~~second quarter of fiscal year 2023, the Company reported total revenue of ~~$137.3~~$123.7 million, ~~up 3.4%~~down (8.0)% from ~~$132.8~~$134.5 million in the same period of fiscal year 2022. During the ~~first~~second quarter of fiscal year 2023, the Company ~~ramped up new programs~~experienced a six-week delay in starting production for a large program with a leading power equipment company. This delayed revenue by approximately $20 million from ~~both longstanding~~the second quarter of fiscal 2023, but production for this program is currently underway and ~~new customers. While~~increasing in the third quarter.In addition, while constraints in the global supply chain continued to limit production, the Company ~~saw some~~continues to see gradual improvements with respect to lead times of certain key components.

Net sales to our largest customers may vary significantly from quarter to quarter depending on the size and timing of customer program commencement, forecasts, delays, and design modifications. We remain dependent on continued net sales to our significant customers and most contracts with customers are not firm long-term purchase commitments. We seek to maintain flexibility in production capacity by employing skilled temporary and short-term labor and by utilizing short-term leases on equipment and manufacturing facilities. In addition, our capacity and core competencies for printed circuit board assemblies, precision molding, sheet metal fabrication, tool making, assembly, and engineering can be applied to a wide variety of products.

Gross profit as a percent of net sales was ~~7.6~~7.2 percent for the ~~first~~second quarter of fiscal year 2023 as compared to ~~7.6~~7.3 percent for the same quarter of the prior fiscal year. During the ~~first~~second quarter of fiscal year 2023, the results were adversely impacted by business interruption and other operational losses related to storm damage to ~~the Company’s facilities in~~our Arkansas which reduced revenue and gross profit. Key Tronic has received initial insurance proceeds to repair the plant and replace equipment, which should be completed by the second half of fiscal year 2023, and these initial coverage amounts, net of equipment book value loss, are included in reported gain on insurance claims during the quarter. In addition,facility as well as increased labor costs. Further, the global supply chain and transportation issues continued to disrupt production, along with increased costs associated to ramping up new programs.

Operating income as a percentage of net sales was ~~2.4~~2.9 percent for the ~~first~~second quarter of fiscal year 2023 compared to ~~1.6~~1.2 percent of operating income as a percentage of net sales for the ~~first~~second quarter of fiscal year 2022. The increase in operating income as a percentage of net sales was primarily driven by the reported gain on insurance claim during the quarter.

Net income for the ~~first~~second quarter of fiscal year 2023 was ~~$1.2~~$1.0 million or ~~$0.11~~$0.09 per diluted share, as compared to net income of ~~$0.8~~$0.6 million or ~~$0.07~~$0.05 per diluted share for the ~~first~~second quarter of fiscal year 2022. Net income for the ~~first~~second quarter of fiscal year 2023 improved based on the increase in operating income generated by the gains on insurance claim of ~~$0.9~~$2.7 million, ~~and increased revenue during the quarter when compared to the results to first quarter of fiscal 2022.~~or approximately $0.19 per share.

Moving into the ~~second~~third quarter of fiscal 2023, global logistics problems, the war in Europe, and China-US geopolitical tensions continue to drive ~~OEM’s~~OEMs to examine their traditional outsourcing strategies. We believe these customers increasingly realize they had become overly dependent on their China-based contract manufacturers for not only product, but also for design and logistics services. Over time, the decision to onshore or near shore production is becoming more widely accepted as a smart long-term strategy.As a result, we ~~are well positioned to benefit~~see opportunities for continued growth. In addition, the headwinds from ~~this growing demand.~~

We have experienced shortages in electronic components used in our products. These shortages can result from strong demand for those components or from problems experienced by suppliers, such as shortages of raw materials. We have also experienced, and expect tothe global supply chain continue to ~~experience, such shortages~~present uncertainty and ~~shutdowns due~~multiple business challenges but do show some signs of gradually abating, particularly with respect to the ~~effects of~~recent price stabilization for some commodity components. At the ~~recent pandemic. These unanticipated component shortages have resulted and could continue to result in curtailed production or delays in production, which may prevent us from timely satisfying~~same time, these price reductions are offset by increasing wages at our performance obligations with our customers. Our inability to satisfy these performance obligations could cause us to experience a reduction in sales, increase in inventory levels and costs, and could adversely affect our operating results. We are carefully monitoring potential supply chain disruptions due to ongoing tightness in the overall component environment and are working to mitigate supply chain constraint risks.North American facilities.

We maintain a strong balance sheet with a current ratio of 2.1 and a debt to equity ratio of 0.9 as of ~~October 1,~~December 31, 2022. Total cash used in operating activities as defined on our cash flow statement was ~~$5.8~~$10.0 million for the ~~three~~six months ended ~~October 1,~~December 31, 2022. We maintain sufficient liquidity for our expected future operations and had ~~$105.4~~$107.6 million in borrowings on our revolving credit facility and ~~$10.6~~$1.8 million remained available at ~~October 1,~~December 31, 2022.

Preparation of our consolidated financial statements in conformity with accounting principles generally accepted in the United States of America requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities. These estimates and assumptions are based on historical results as well as future expectations. Actual results could vary from our estimates and assumptions.


		Three Months Ended													Three Months Ended
		October 1, 2022		% of net sales		October 2, 2021		% of net sales		$ change		% point change			December 31, 2022		% of net sales		January 1, 2022		% of net sales		$ change		% point change
Net sales	Net sales	$	137,263	100.0	%	$	132,762	100.0	%	$	4,501	—	%	Net sales	$	123,708	100.0	%	$	134,456	100.0	%	$	(10,748)	—	%
Cost of sales	Cost of sales	126,884		92.4	%	122,624		92.4	%	4,260		—	%	Cost of sales	114,788		92.8	%	124,648		92.7	%	(9,860)		0.1	%
Gross profit	Gross profit	10,379		7.6	%	10,138		7.6	%	241		—	%	Gross profit	8,920		7.2	%	9,808		7.3	%	(888)		(0.1)	%
Research, development and engineering	Research, development and engineering	2,296		1.7	%	2,449		1.8	%	(153)		(0.1)	%	Research, development and engineering	2,287		1.8	%	2,498		1.9	%	(211)		(0.1)	%
Selling, general and administrative	Selling, general and administrative	5,656		4.1	%	5,595		4.2	%	61		(0.1)	%	Selling, general and administrative	5,735		4.6	%	5,659		4.2	%	76		0.4	%
Gain on insurance proceeds, net of losses	Gain on insurance proceeds, net of losses	(934)		(0.7)	%	—		—	%	(934)		(0.7)	%	Gain on insurance proceeds, net of losses	(2,710)		(2.2)	%	—		—	%	(2,710)		(2.2)	%
Total operating expenses	Total operating expenses	7,018		5.1	%	8,044		6.0	%	(1,026)		(0.9)	%	Total operating expenses	5,312		4.2	%	8,157		6.1	%	(2,845)		(1.9)	%
Operating income	Operating income	3,361		2.4	%	2,094		1.6	%	1,267		0.8	%	Operating income	3,608		2.9	%	1,651		1.2	%	1,957		1.7	%
Interest expense, net	Interest expense, net	1,887		1.4	%	992		0.7	%	895		0.7	%	Interest expense, net	2,507		2.0	%	1,095		0.8	%	1,412		1.2	%
Income before income taxes	Income before income taxes	1,474		1.1	%	1,102		0.8	%	372		0.3	%	Income before income taxes	1,101		0.9	%	556		0.4	%	545		0.5	%
Income tax provision	Income tax provision	322		0.2	%	287		0.2	%	35		—	%	Income tax provision	134		0.1	%	(31)		—	%	165		0.1	%
Net income	Net income	$	1,152	0.8	%	$	815	0.6	%	$	337	0.2	%	Net income	$	967	0.8	%	$	587	0.4	%	$	380	0.4	%

The ~~$4.5~~$10.7 million ~~increase~~decrease in net sales from the prior year period was primarily due to a six-week delay in starting production for a large program with a leading power equipment company. This delayed revenue by approximately $20 million from the ~~successful ramp~~second quarter of ~~new customer programs~~fiscal 2023, but production for ~~new~~this program is currently underway and legacy customers. The Company’s revenue continued to be constrained by tightening worldwide supply chain and transportation and logistics issues, but these problems do show signs of gradually abating.increasing in the third quarter.

Gross profit as a percentage of net sales for the three months ended ~~October 1,~~December 31, 2022 was ~~7.6~~7.2 percent compared to ~~7.6~~7.3 percent for the three months ended ~~October 2, 2021.~~January 1, 2022. Gross profits percentages ~~were flat~~slightly decreased as a result of the ~~loss of production~~business interruption and other operational losses related to storm damage to our Arkansas facility, as well as by preparations for expected sales growth in ~~Arkansas~~the second quarter and ~~increasing~~increased labor costs ~~associated to new program ramps offset by~~in both the ~~efficiencies gained in additional revenue.~~US and Mexico.

Included in gross profit are charges related to reductions in the carrying value of our inventory due to obsolescence. We recorded ~~a provision~~an impairment of approximately $175,000 and $138,000 for obsolete inventory during the three months ended ~~October~~December 31, 2022 and January 1, 2022, ~~and October 2, 2021,~~ respectively. We adjust the carrying value for estimated obsolescence as necessary in an amount equal to the difference between the cost of inventory and its net realizable value based on assumptions as to future demand and market conditions. The provisions are established for inventory that we have determined customers are not contractually responsible for and for inventory that we believe customers will be unable to purchase.

There were no significant changes to operating expenses during the presented quarters, other than the gain on insurance proceeds of ~~$934,000~~$2.7 million recorded in the ~~first~~second quarter of fiscal 2023. Total research, development, and engineering (RD&E) expenses were $2.3 million during the three months ended ~~October 1,~~December 31, 2022 and ~~$2.4~~$2.5 million during the three months ended ~~October 2, 2021,~~January 1, 2022, respectively. Total RD&E expenses as a percent of net sales were ~~1.7 percent during the three months ended October 1, 2022 and~~ 1.8 percent during the three months ended ~~October 2, 2021.~~December 31, 2022 and 1.9 percent during the three months ended January 1, 2022.

Total selling, general and administrative (SG&A) expenses were $5.7 million during the three months ended ~~October 1,~~December 31, 2022 compared to ~~$5.6~~$5.7 million for the three months ended ~~October 2, 2021.~~January 1, 2022. Total SG&A expenses as a percentage of net sales were ~~4.1~~4.6 percent for the three months ended ~~October 1,~~December 31, 2022 and 4.2 percent for the three months ended ~~October 2, 2021.~~January 1, 2022.

The effective tax rate for the three months ended ~~October 1,~~December 31, 2022 was ~~21.8~~12.2 percent compared to ~~26.0~~(5.6) percent for the three months ended ~~October 2, 2021.~~January 1, 2022. The ~~decrease~~increase was primarily due to ~~increased~~ federal research and development tax credits constituting a lower percentage of income before taxes and the impact of fluctuations in foreign exchange rates. For further information on taxes see Note 5 of the “Notes to Consolidated Financial Statements.”

Our judgments regarding deferred tax assets and liabilities may change due to changes in market conditions, changes in estimates, changes in tax laws or other factors. If assumptions and estimates change in the future the deferred tax assets and liability will be adjusted accordingly and any increase or decrease will result in an additional deferred income tax expense or benefit in subsequent periods.


	Six Months Ended
	December 31, 2022		% of net sales		January 1, 2022		% of net sales		$ change		% point change
Net sales	$	260,971	100.0	%	$	267,218	100.0	%	$	(6,247)	—	%
Cost of sales	241,672		92.6	%	247,272		92.5	%	(5,600)		0.1	%
Gross profit	19,299		7.4	%	19,946		7.5	%	(647)		(0.1)	%
Research, development and engineering	4,583		1.8	%	4,947		1.9	%	(364)		(0.1)	%
Selling, general and administrative	11,391		4.4	%	11,254		4.2	%	137		0.2	%

Gain on insurance proceeds, net of losses	(3,644)		(1.4)	%	—		—	%	(3,644)		(1.4)	%
Total operating expenses	12,330		4.8	%	16,201		6.1	%	(3,871)		(1.3)	%
Operating income	6,969		2.7	%	3,745		1.4	%	3,224		1.3	%
Interest expense, net	4,394		1.7	%	2,087		0.8	%	2,307		0.9	%
Income before income taxes	2,575		1.0	%	1,658		0.6	%	917		0.4	%
Income tax provision	456		0.2	%	256		0.1	%	200		0.1	%
Net income	$	2,119	0.8	%	$	1,402	0.5	%	$	717	0.3	%

The $(6.2) million decrease in net sales from the prior year period was primarily due to a six-week delay in starting production for a large program with a leading power equipment company. This delayed revenue by approximately $20 million from the second quarter of fiscal 2023, but was offset by the successful ramp up of new customer programs for new and legacy customers during Q1 of fiscal 2023.

Gross profit as a percentage of net sales for the six months ended December 31, 2022 was 7.4 percent compared to 7.5 percent for the six months ended January 1, 2022. Gross profits percentages slightly decreased as a result of the business interruption and other operational losses related to storm damage to our Arkansas facility, as well as by preparations for expected sales growth in the second quarter and increased labor costs in both the US and Mexico.

Included in gross profit are charges related to reductions in the carrying value of our inventory due to obsolescence. We recorded an impairment of approximately $355,000 and $365,000 for obsolete inventory during the ~~fiscal year 2023.~~six months ended December 31, 2022 and January 1, 2022, respectively. We adjust the carrying value for estimated obsolescence as necessary in an amount equal to the difference between the cost of inventory and its net realizable value based on assumptions as to future demand and market conditions. The provisions are established for inventory that we have determined customers are not contractually responsible for and for inventory that we believe customers will be unable to purchase.

On ~~October 1,~~December 31, 2022, we had an order backlog of approximately ~~$380.0~~$404.0 million. This compares with a backlog of approximately ~~$320.9~~$333.1 million on ~~October 2, 2021.~~January 1, 2022. The increase in order backlog is related to increases in demand and continuing supply chain issues that have delayed production. Order backlog consists of purchase orders received for products expected to be shipped within the next 12 months, although shipment dates are subject to change due to design modifications or changes in other customer requirements. Order backlog should not be considered an accurate measure of future net sales.

The ~~$5.8~~$10.0 million of net cash used in operating activities for the ~~three~~six months ended ~~October 1,~~December 31, 2022 is primarily related to ~~$0.2~~$2.1 million in net income for the period adjusted for ~~$2.4~~$4.7 million of depreciation and amortization, a ~~$1.8~~$1.6 million increase in accounts receivable, a ~~$13.5~~$16.0 million increase in inventory, a ~~$2.8~~$4.0 million decrease in accrued compensation and vacation, a ~~$3.6~~$2.5 million increase in other assets, partially offset by a ~~$12.7~~$19.3 million increase in accounts payable, a ~~$2.2~~$10.5 million increase in other liabilities and a ~~$4.4~~$6.4 million decrease in contract assets.

The ~~$14.6~~$10.5 million of net cash used in operating activities for the ~~three~~six months ended ~~October 2, 2021~~January 1, 2022 is primarily related to ~~$0.8~~$1.4 million in net income for the period adjusted for ~~$1.3~~$2.6 million of depreciation and amortization, a ~~$16.2~~$13.1 million increase in accounts receivable, a ~~$5.8~~$20.4 million increase in inventory, a ~~$3.0~~$4.1 million decrease in accrued compensation and vacation, a $13.5 million increase in other assets, partially offset by a ~~$18.8~~$39.0 million increase in accounts payable, and a ~~$1.1~~$1.2 million ~~decrease~~increase in contract assets.

Accounts receivable fluctuates based on the timing of shipments, terms offered and collections that occurred during the quarter. While overall net sales are not typically seasonal in nature, we ship the majority of our product during the latter half of the quarter. We purchase inventory based on customer forecasts and orders, and when those forecasts and orders change, the amount of inventory may also fluctuate. Accounts payable fluctuates with changes in inventory levels, volume of inventory purchases, negotiated supplier terms and taking advantage of early pay discounts.

Cash used in investing activities was ~~$2.5~~$0.4 million during the ~~three~~six months ended ~~October 1,~~December 31, 2022 as compared to ~~$1.8~~$2.8 million during the ~~three~~six months ended ~~October 2, 2021.~~January 1, 2022. Our primary investing activity during the ~~three~~six months ended ~~October~~December 31, 2022 and January 1, 2022, ~~and October 2, 2021,~~ was purchasing equipment to support increased production levels for new programs.

Leases are often utilized when potential technical obsolescence and funding requirement advantages outweigh the benefits of equipment ownership. Total capital expenditures are expected to be $9.0 million during the fiscal year, a significant portion of which may be funded through finance leases. Capital expenditures and periodic lease payments are expected to be financed with internally generated funds as well as our revolving line of credit facility and equipment term loan.

Cash provided by financing activities was ~~$8.8~~$9.5 million during the ~~three~~six months ended ~~October 1,~~December 31, 2022 as compared to ~~$14.5~~$10.9 million in the same period of the previous fiscal year. Our primary financing activities during the ~~three~~six months ended ~~October~~December 31, 2022 and six months ended January 1, 2022, ~~and three months ended October 2, 2021,~~ were borrowings and repayments under our revolving line of credit facility and term loans.

Our cash requirements are affected by the level of current operations and new programs. We believe that projected cash from operations, funds available under the revolving credit facility and leasing capabilities will be sufficient to meet our working and fixed capital requirements for the foreseeable future. The Company further notes projected cash from operations from increased demand from certain customers will be partially offset by an anticipated slowdown in collections from other customers and increasing inventory levels in efforts to mitigate supply chain constraint risks.

As of ~~October 1,~~December 31, 2022, we had approximately ~~$2.1~~$1.3 million of cash held by foreign subsidiaries. If cash is to be repatriated in the future from these foreign subsidiaries, the Company would be subject to certain withholding taxes in the foreign jurisdictions. The total amount of tax payments required for the amount of foreign subsidiary cash on hand as of ~~October 1,~~December 31, 2022 would approximate ~~$12,000.~~$32,000. We have accrued withholding taxes for expected future repatriation of foreign earnings as discussed in Note 65 of the “Notes to Consolidated Financial Statements.”

Our quarterly operating results have varied in the past and may vary in the future due to a variety of factors, including adverse changes in the U.S. and global macroeconomic environment, volatility in overall demand for our customers’ products, success of customers’ programs, timing of new programs, new product introductions or technological advances by us, our customers and our competitors, and changes in pricing policies by us, our customers, our suppliers, and our competitors. Our customer base is diverse in the markets they serve, however, decreases in demand, particularly from customers in certain industries could affect future quarterly results. Additionally, our customers could be adversely impacted by illiquidity in the credit markets which could directly impact our operating results.

Component procurement, production schedules, personnel and other resource requirements are based on estimates of customer requirements. Occasionally, our customers may request accelerated production that can stress resources and reduce operating margins. Conversely, our customers may abruptly lower or cancel production which may lead to a sudden, unexpected increase in inventory or accounts receivable for which we may not be reimbursed even when under contract with customers. In addition, because many of our operating expenses are relatively fixed, a reduction in customer demand can harm our gross profit and operating results. The products which we manufacture for our customers have relatively short product lifecycles. Therefore, our business, operating results and financial condition are dependent in a significant way on our ability to obtain orders from new customers and new product programs from existing customers.

Operating results can also fluctuate if changes are made to significant estimates and assumptions. Significant estimates and assumptions include the allowance for doubtful receivables, provision for obsolete and non-saleable inventory, stock-based compensation, the valuation allowance on deferred tax assets, impairment of long-lived assets, long-term incentive compensation accrual, the provision for warranty costs, and the impact of hedging activities.

Adverse economic conditions and uncertainty in the global economy such as unstable global financial and credit markets, inflation, and recession can negatively impact our business. Unfavorable economic conditions could affect the demand for our customers’ products by triggering a reduction in orders as well as a decline in forecasts which could adversely affect our sales in future periods. Additionally, the financial strength of our customers and suppliers and their ability to obtain and rely on credit financing may affect their ability to fulfill their obligations to us and have an adverse effect on our financial results.

Adverse macroeconomic conditions as a result of COVID-19 have and may continue to affect our business. The conditions affect the Company’s ability to predict and plan for future supply chain disruptions, fluctuations in customer demand and costs, and the ability to operate as there is uncertainty over future temporary closures. Inflation has also risen globally to historically high levels. If the inflation rate continues to increase, the costs of labor and other expenses could also increase. We may not be able to increase our product prices enough to offset these increased costs. In addition, any increase in our product prices may reduce our future customer orders and profitability. Inflation may further exacerbate other risk factors discussed in this Quarterly Report on Form 10-Q, including disruptions to international operations.

At present, our customer base is concentrated and could become more or less concentrated. There can be no assurance that our principal customers will continue to purchase products from us at current levels. Moreover, we typically do not enter into long-term volume purchase contracts with our customers, and our customers have certain rights to extend or delay the shipment of their orders. We, however, typically require that our customers contractually agree to buy back inventory purchased within specified lead times to build their products if not used.

The loss of one or more of our major customers, or the reduction, delay or cancellation of orders from such customers, due to economic conditions or other forces, could materially and adversely affect our business, operating results and financial condition. The contraction in demand from certain industries could impact our customer orders and have a negative impact on our operations over the foreseeable future. Additionally, if one or more of our customers were to become insolvent or otherwise unable to pay for the manufacturing services provided by us, our operating results and financial condition would be adversely affected.

We are dependent on many suppliers, including sole source suppliers, to provide key components and raw materials used in manufacturing customers’ products. We have seen supply shortages in certain electronic components. In addition, our suppliers' facilities may also experience earthquakes, tsunamis and other natural disasters which may cause a shortage of components. This can result in longer lead times and the inability to meet our customers request for flexible production and extended shipment dates. If demand for components outpaces supply, capacity delays could affect future operations. Delays in deliveries from suppliers or the inability to obtain sufficient quantities of components and raw materials have and may continue to cause delays or reductions in shipment of products to our customers which could adversely affect our operating results and damage customer relationships.

Competitors may offer customers lower prices on certain high volume programs. This could result in price reductions, reduced margins and loss of market share, all of which would materially and adversely affect our business, operating results, and financial condition. If we were unable to provide comparable or better manufacturing services at a lower cost than our competitors, it could cause sales to decline. In addition, competitors can copy our non-proprietary designs and processes after we have invested in development of products for customers, thereby enabling such competitors to offer lower prices on such products due to savings in development costs.

We have manufacturing operations located in Mexico and China. A significant portion of our operations are denominated in the Mexican peso and the Chinese currency, the renminbi ("RMB"). Currency exchange rates fluctuate daily as a result of a number of factors, including changes in a country's political and economic policies. Volatility in the currencies of our entities and the United States dollar, as well as inflationary costs, could seriously harm our business, operating results and financial condition. The primary impact of currency exchange fluctuations is on the cash, receivables, payables and expenses of our operating entities. As part of our hedging strategy, we currently use Mexican peso forward contracts to hedge foreign currency fluctuations for a portion of our Mexican peso denominated expenses. We currently do not hedge expenses denominated in RMB. Unexpected losses could occur from increases in the value of these currencies relative to the United States dollar.

As a result of COVID-19, significant currency exchange fluctuations can occur causing unexpected losses. Future temporary closures of production facilities in Mexico could also cause significant changes in our ability to qualify for hedge accounting treatment of our forward contracts to hedge foreign currency fluctuations. However, given the unprecedented nature of the pandemic the FASB staff believes that an entity may apply the exception in paragraph 815-30-40-4 for rare cases caused by extenuating circumstances that are related to the nature of the forecasted transaction and are outside the control or influence of an entity to delays in the timing of the forecasted transactions if those delays are related to the effects of the COVID-19 pandemic and are considered probable to still occur. In addition, the FASB staff believes that it would be acceptable for an entity to determine that missed forecasts related to the effects of the COVID-19 pandemic need not be considered when determining whether it has exhibited a pattern of missing forecasts that would call into question its ability to accurately predict forecasted transactions and the propriety of using cash flow hedge accounting in the future for similar transactions.

Our future success depends in large part on the continued service of our key technical, marketing and management personnel and on our ability to continue to attract and retain qualified production employees. There can be no assurance that we will be successful in attracting and retaining such personnel, particularly in our manufacturing locales that may be experiencing high demand for similar key personnel. The loss of key employees could have a material adverse effect on our business, operating results and financial condition.

Start-up costs, the management of labor and equipment resources in connection with the establishment of new programs and new customer relationships, and the need to obtain required resources in advance can adversely affect our gross margins and operating results. These factors are particularly evident in the ramping stages of new programs. These factors also affect our ability to efficiently use labor and equipment. We are currently managing a number of new programs. Consequently, our exposure to these factors has increased. In addition, if any of these new programs or new customer relationships were terminated, our operating results could be harmed, particularly in the short term. We may not be able to recoup these start-up costs or replace anticipated new program revenues.

Changes in demand for customer products reduce our ability to accurately estimate the future requirements of our customers. This makes it difficult to schedule production and maximize utilization of our manufacturing capacity. We must determine the levels of business that we will seek and accept from customers, set production schedules, commit to procuring inventory, and allocate personnel and resources, based on our estimates of our customers' requirements. Customers can require sudden increases and decreases in production which can put added stress on resources and reduce margins. Sudden decreases in production can lead to excess inventory on hand which may or may not be reimbursed by our customers even when under contract.

Continued growth could further lead to capacity constraints. We may need to transfer production to other facilities, acquire new facilities, or outsource production which could negatively impact gross margin. The Company has been able to manage the arrival of components in an effort to control inventory levels of customers that have seen sharp decreases in demand, as a result of COVID-19.

We are subject to a variety of domestic and foreign environmental regulations relating to the use, storage, and disposal of materials used in our manufacturing processes. In addition, increasing governmental focus on climate change may result in new environmental regulations that may negatively affect us, our vendors or our customers. As a result, we may incur additional costs or obligations in complying with any new environmental and reporting requirements, as well as increased indirect costs resulting from our vendors or customers that get passed on to us.

If we fail to comply with any present or future regulations, we could be subject to future liabilities or the suspension of current manufacturing operations. In addition, such regulations could restrict our ability to expand our operations or could require us to acquire costly equipment, substitute materials, or incur other significant expenses to comply with government regulations.

We manufacture and design products to our customers’ specifications, and, in some cases, our manufacturing processes and facilities may need to comply with applicable statutory and regulatory requirements. For example, medical devices that we manufacture or design, as well as the facilities and manufacturing processes that we use to produce them, are regulated by the Food and Drug Administration and non-U.S. counterparts of this agency. In addition, our customers’ products and the manufacturing processes that we use to produce them often are highly complex. As a result, products that we manufacture may at times contain manufacturing or design defects, and our manufacturing processes may be subject to errors or not be in compliance with applicable statutory and regulatory requirements. Defects in the products we manufacture or design, whether caused by a design, manufacturing or component failure or error, or deficiencies in our manufacturing processes, may result in delayed shipments to customers or reduced or canceled customer orders. If these defects or deficiencies are significant, our business reputation may also be damaged. The failure of the products that we manufacture or our manufacturing processes and facilities to comply with applicable statutory and regulatory requirements may subject us to legal fines or penalties and, in some cases, require us to shut down or incur considerable expense to correct a manufacturing process or facility. Our customers are required to indemnify us against liability associated with designing products to meet their specifications. However, if our customers are responsible for the defects, they may not, or may not have resources to, assume responsibility for any costs or liabilities arising from these defects, which could expose us to additional liability claims.

Our business is experiencing growth which can place considerable additional demands upon our management team and our operational, financial and management information systems. Our ability to manage growth effectively requires us to continue to implement and improve these systems; avoid cost overruns; maintain customer, supplier and other favorable business relationships during possible transition periods; continue to develop the management skills of our managers and supervisors; and continue to train, motivate and manage our employees. Our failure to effectively manage growth could have a material adverse effect on our results of operations.

Certain components that we use in our manufacturing process are petroleum-based. In addition, we, along with our suppliers and customers, rely on various energy sources in our transportation activities. While significant uncertainty currently exists about the future levels of energy prices, a significant increase, such as the increased fuel prices experienced in fiscal year 2022, is possible. Increased energy prices could cause an increase to our raw material costs and transportation costs. In addition,

We are increasingly dependent on digital technologies and services to conduct our operations. We use these technologies for internal purposes, including data storage, processing and transmissions, as well as in our interactions with vendors and customers. Digital technologies and services are subject to the risk of cybersecurity incidents and some incidents can remain undetected for a period of time.

We routinely monitor our systems for cyber threats and have processes in place to detect and remediate vulnerabilities. Nevertheless, we have experienced attempted security breaches, such as phishing emails and other targeted attacks. We expect that our operations will continue to be subject to cyber threats, and any future cybersecurity incident could significantly disrupt our operations.

Cybersecurity incidents could also result in the misappropriation of proprietary or confidential information of the Company or that of its customers, employees, vendors or customers. We expect to incur costs in the future to mitigate against cybersecurity incidents as threats are expected to continue to become more persistent and sophisticated. If our systems for protecting against cybersecurity incidents prove not to be sufficient, we could be adversely affected by, among other things, loss of or damage to intellectual property, proprietary or confidential information, or employee, vendor or customer data; interruption of our business operations; and increased costs to prevent, respond to or mitigate cybersecurity incidents. These risks could harm our reputation and our relationships with employees, vendors and customers and may result in claims or enforcement actions and investigations against us.

We rely on information technology networks and systems to process, transmit and store electronic information. In particular, we depend on our information technology infrastructure for a variety of functions, including worldwide financial reporting, inventory management, procurement, invoicing and email communications. Any of these systems may be susceptible to outages due to fire, floods, power loss, telecommunications failures, terrorist attacks and similar events. If we or our vendors are unable to prevent such outages, our operations could be disrupted.

The markets for our customers’ products are characterized by rapidly changing technology, evolving industry standards, frequent new product introductions and short product life cycles. The introduction of products embodying new technologies or the emergence of new industry standards can render existing products obsolete or unmarketable. Our success will depend upon our customers’ ability to enhance existing products and to develop and introduce, on a timely and cost-effective basis, new products that keep pace with technological developments and emerging industry standards and address evolving and increasingly sophisticated customer requirements. Failure of our customers to do so could substantially harm our customers’ competitive positions. There can be no assurance that our customers will be successful in identifying, developing and marketing products that respond to technological change, emerging industry standards or evolving customer requirements.

We place our cash with high credit quality institutions. At times, such balances may be in excess of the federal depository insurance limit or may be on deposit at institutions which are not covered by insurance. If such institutions were to become insolvent during which time it held our cash and cash equivalents in excess of the insurance limit, it could be necessary to obtain other credit financing to operate our facilities.

There is no assurance that we will be able to retain or renew our credit agreements in the future. In the event the business grows rapidly or there is uncertainty in the macroeconomic climate, additional financing resources could be necessary in the current or future fiscal years. There is no assurance that we will be able to obtain equity or debt financing at acceptable terms, or at all in the future. In addition, we have restrictive covenants with our financial institution which could impact how we manage our business. If we cannot meet our financial covenants, our borrowings could become immediately payable which could have a material adverse impact on our financial statements. For a summary of our banking arrangements, see Note 4 Long-Term Debt of the “Notes to Consolidated Financial Statements.”

We are exposed to interest rate risk under our revolving line of credit and term loan. We have not historically hedged the interest rate on our credit facility; therefore, unless we do so, significant changes in interest rates could adversely affect our results of operations. For a summary of our debt obligations, see Footnote “Long-Term Debt” of the “Notes to Consolidated Financial Statements.”

In addition, the U.K.’s Financial Conduct Authority, which regulates LIBOR, has confirmed that LIBOR-indexed rates will cease after June 30, 2023, with the remaining IBOR-indexed rates ceasing on December 31, 2021. The Federal Reserve Board and the Federal Reserve Bank of New York identified Secured Overnight Financing Rate (“SOFR”) as its preferred alternative rate for LIBOR for debt and derivative financial instruments.

Our stock price has and may continue to be subject to wide fluctuations and possible rapid increases or declines over a short time period. These fluctuations may be due to factors specific to us such as our stock's thinly traded nature, variations in quarterly operating results, changes in earnings estimates, or the Audit Committee's internal investigation, or to factors relating to the contract manufacturing industry or to the securities markets in general, which, in recent years, have experienced significant price fluctuations. These fluctuations often have been unrelated to the operating performance of the specific companies whose stocks are traded. In addition, holders of our common stock will suffer immediate dilution to the extent outstanding equity awards are exercised to purchase common stock.

We identified a material weakness in our internal control over financial reporting and concluded that our disclosure controls and procedures were not effective as of December 26, 2020 and April 3, 2021. If we fail to properly remediate any future deficiencies or material weaknesses or to maintain proper and effective internal controls, our business and financial condition could be materially adversely impacted.

As previously disclosed, we concluded that our disclosure controls and procedures were not effective as of December 26, 2020 and April 3, 2021, due to the existence of a material weakness in our internal control over financial reporting. While we undertook remediation efforts to address the identified deficiencies and have concluded that the material weakness was remediated as of July 3, 2021, we cannot provide assurance that we will be able to conclude that our controls will be effective in the future. We also cannot guarantee that additional significant deficiencies or material weaknesses in our internal control over financial reporting will not arise or be identified in the future.

If additional deficiencies in our internal control over financial reporting are discovered or occur in the future, our consolidated financial statements may contain material misstatements and we could be required to restate our financial results and incur the additional costs and expenses associated therewith. Moreover, because of the inherent limitations of any control system, material misstatements due to error or fraud may not be prevented or detected on a timely basis, or at all. If we are unable to provide reliable and timely financial reports in the future, our business and reputation may be further harmed. Restated financial statements and failures in internal controls may also cause us to fail to meet additional reporting obligations, negatively affect investor confidence in our management and the accuracy of our financial statements and disclosures, or result in adverse publicity and concerns from investors, any of which could have a negative effect on the price of our common stock, subject us to regulatory investigations and penalties or stockholder litigation, and materially adversely impact our business, financial condition, results of operations and cash flows.

We have incurred, and may continue to incur, significant expenses related to legal, accounting and other professional services in connection with matters relating to or arising from the subject of the Audit Committee’s internal investigation. As a result of the internal investigation, we have taken and continue to take a number of steps in order to remediate identified deficiencies in our internal control over financial reporting and attempt to reduce the risk of future recurrence. The validation of the efficacy of these remedial steps have resulted in us incurring additional near term expenses, and to the extent these steps are not successful, we may incur significant additional time and expense.

In addition, we are cooperating with the SEC regarding matters related to the internal investigation. The completion of the internal investigation will not automatically resolve the SEC’s inquiries. If the SEC or any other regulator were to commence legal action against us, we could be required to pay significant additional legal fees, as well as penalties and become subject to injunctions, cease and desist orders or other remedies. We can provide no assurances as to the outcome of any governmental inquiry or investigation. Further, we, our officers and members of our board of directors could be named as defendants in lawsuits asserting claims arising out of the subject matter of the Audit Committee’s internal investigation. As a result of any legal proceedings and any related indemnification requirements to our officers and directors, we could be required to pay additional legal fees and/or monetary damages that may be in excess of our insurance coverage or may have additional penalties or other remedies imposed against us or our officers and directors.

Management does not expect that our disclosure controls and procedures and internal controls over financial reporting will prevent all errors or fraud. A control system is designed to give reasonable, but not absolute, assurance that the objectives of the control system are met. In addition, any control system reflects resource constraints and the benefits of controls must be considered relative to their costs. Inherent limitations of a control system may include: judgments in decision making may be faulty, breakdowns can occur simply because of error or mistake and controls can be circumvented by collusion or management override. Due to the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and may not be detected.

In the past, we have been notified of claims relating to various matters including contractual matters, intellectual property rights or other issues arising in the ordinary course of business. In the event of such a claim, we may be required to spend a significant amount of money to defend or otherwise address the claim. Any litigation or dispute resolution, even where a claim is without merit, could result in substantial costs and diversion of resources. Accordingly, the resolution or adjudication of such disputes, even those encountered in the ordinary course of business, could have a material effect on our business, consolidated financial conditions and results of operations.

We are subject to additional requirements contained in the Sarbanes-Oxley Act of 2002 (the Sarbanes-Oxley Act) and more recently the Dodd-Frank Wall Street Reform and Consumer Protection Act (the Dodd-Frank Act). The Sarbanes-Oxley and Dodd-Frank Acts required or will require changes in some of our corporate governance, securities disclosure and compliance practices. In response to the requirements of the Sarbanes-Oxley and Dodd-Frank Acts, the SEC and NASDAQ promulgated new rules and additional rulemaking is expected in the future. Compliance with these new rules and future rules has increased and may increase further our legal, financial and accounting costs as well as a potential risk of noncompliance. Absent significant changes in related rules, which we cannot assure, we anticipate some level of increased costs related to these new regulations to continue indefinitely. We also expect these developments to make it more difficult and more expensive to obtain director and officer liability insurance, and we may be forced to accept reduced coverage or incur substantially higher costs to obtain coverage. Likewise, these developments may make it more difficult for us to attract and retain qualified members of our Board of Directors or qualified management personnel. Further, the costs associated with the compliance with and implementation of procedures under these and future laws and related rules could have a material impact on our results of operations. In addition, the costs associated with noncompliance with additional securities laws and regulations could also impact our business.

Our consolidated financial statements are prepared in conformity with accounting standards generally accepted in the United States, or U.S. GAAP. These principles are subject to amendments made primarily by the Financial Accounting Standards Board (FASB) and the Securities and Exchange Commission (SEC). A change in those policies can have a significant effect on our reported results and may affect our reporting of transactions which are completed before a change is announced. Changes to accounting rules or challenges to our interpretation or application of the rules by regulators may have a material adverse effect on our reported financial results or on the way we conduct business.

We have various forms of business and liability insurance which we believe are appropriate based on the needs of companies in our industry. As a result, not all of our potential business risks or potential losses would be covered by our insurance policies. If we sustain a significant claim or loss which is not covered by insurance, our net income could be negatively impacted.

Any current or future acquisitions may require additional equity financing, which could be dilutive to our existing shareholders, or additional debt financing, which could potentially affect our credit ratings. Any downgrades in our credit ratings associated with an acquisition could adversely affect our ability to borrow by resulting in more restrictive borrowing terms. To integrate acquired businesses, we must implement our management information systems, operating systems and internal controls, and assimilate and manage the personnel of the acquired operations. The integration of acquired businesses may be further complicated by difficulties managing operations in geographically dispersed locations. The integration of acquired businesses may not be successful and could result in disruption by diverting management’s attention from the core business. In addition, the integration of acquired businesses may require that we incur significant restructuring charges or other increases in our expenses and working capital requirements, which reduce our return on invested capital.

Acquisitions may involve numerous other risks and challenges including but not limited to: potential loss of key employees and customers of the acquired companies; the potential for deficiencies in internal controls at acquired companies; lack of experience operating in the geographic market or industry sector of the acquired business; constraints on available liquidity, and exposure to unanticipated liabilities of acquired companies. These and other factors could harm our ability to achieve anticipated levels of profitability at acquired operations or realize other anticipated benefits of an acquisition, and could adversely affect our consolidated business and operating results.

We are subject to the risk of fluctuating interest rates in the normal course of business. Our major market risk relates to our secured debt. Our asset-based senior secured revolving credit facility and equipment financing facility are secured by substantially all of our assets. The interest rates applicable to our asset-based senior secured revolving credit facility fluctuate with LIBOR rates. There was outstanding ~~$105.4~~$107.6 million in borrowings under our asset-based senior secured revolving credit facility and $7.8 million outstanding on our equipment financing facilities as of ~~October 1,~~December 31, 2022. See “Management’s Discussion and Analysis of Financial Condition and Results of Operations – Capital Resources and Liquidity” and Note 4 – “Long-Term Debt” to the Consolidated Financial Statements for additional information regarding our revolving credit facility and term loans.

A significant portion of our operations are in foreign locations. As a result, transactions occur in currencies other than the U.S. dollar. Exchange rate fluctuations among other currencies used by us would directly or indirectly affect our financial results. From time to time, we use Mexican peso forward contracts to hedge foreign currency fluctuations for a portion of our Mexican peso denominated expenses. As of ~~October 1,~~December 31, 2022, the Company did not have any outstanding foreign currency forward contracts. For the three months ended ~~October 1,~~December 31, 2022, the Company did not enter into or settle any foreign currency forward contracts.

It is the responsibility of our management to establish, maintain, and monitor disclosure controls and procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Securities Exchange Act of 1934 (the “Exchange Act”) are recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission rules and forms. Additionally, these disclosure controls include controls and procedures that are designed to accumulate and communicate the information required to be disclosed to our company’s Chief Executive Officer and Chief Financial Officer, allowing for timely decisions regarding required disclosures.

Item 6.

Exhibits

3.1

Articles of Incorporation, incorporated by reference to the Company’s Form 10-K for the fiscal year ended July 3, 2021

3.2

Bylaws, as amended, incorporated by reference to the Company’s Form 10-K for the fiscal year ended July 3, 2021

~~10.1~~

Third Amendment to Loan and Security Agreement, dated August 26,2022, among the Company, Bank of America, N.A., and certain other parties, incorporated by reference to Exhibit 10.2 to the Company’s Form 10-K filed September 14,2022.

31.1

Certification of Chief Executive Officer (Exchange Act Rules 13(a)-14 and 15(d)-14)

31.2

Certification of Chief Financial Officer (Exchange Act Rules 13(a)-14 and 15(d)-14)

32.1

Certification of Chief Executive Officer (18 U.S.C. 1350)

32.2

Certification of Chief Financial Officer (18 U.S.C. 1350)

101.INS

Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Label Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (formatted as inline XBRL with applicable taxonomy extention information contained in Exhibits 101.INS, 101.SCH, 101.CAL, 101.DEF, 101.LAB and 101.PRE)


Washington			91-0849125
(State of Incorporation)			(I.R.S. Employer Identification No.)


Title of each class	Trading Symbol	Name of each exchange on which registered
Common Stock, no par value	KTCC	NASDAQ Global Market


		Page No.

PART I.	FINANCIAL INFORMATION:

Item 1.	Financial Statements (Unaudited):	3

	Condensed Consolidated Balance Sheets	3

	Condensed Consolidated Statements of Income	4

	Condensed Consolidated Statements of Comprehensive Income	5

	Condensed Consolidated Statements of Cash Flows	6

	Condensed Consolidated Statements of Shareholders’ Equity	7

	Notes to Condensed Consolidated Financial Statements	8

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	19

Item 3.	Quantitative and Qualitative Disclosures about Market Risk	2932

Item 4.	Controls and Procedures	2932

PART II.	OTHER INFORMATION:

Item 1.	Legal Proceedings	3032

Item 1A.	Risk Factors	3032

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds*

Item 3.	Defaults upon Senior Securities*

Item 4.	Mine Safety Disclosures*

Item 5.	Other Information*

Item 6.	Exhibits	3033

Signatures		3134


	July 29, 2022		August 9, 2021
SARs Granted	145,000		165,000
Strike Price	$	5.10	$	7.17
Fair Value	$	2.09	$	2.73


	Contract Assets
Beginning balance, July 2, 2022	$	21,974
Revenue recognized	~~134,557~~254,207
Amounts collected or invoiced	~~(130,173)~~(247,852)
Ending balance, ~~October 1,~~December 31, 2022	$	~~26,358~~28,329


	Revenue
Recognition	Three Months Ended
	October 1, 2022		October 2, 2021
Over-Time	$	134,558	$	129,481
Point-in-Time	2,705		3,281
Total	$	137,263	$	132,762


KEY TRONIC CORPORATION

/s/ CRAIG D. GATES
Craig D. Gates	Date:	~~November~~February 9, ~~2022~~2023
President and Chief Executive Officer
(Principal Executive Officer)

/s/ BRETT R. LARSEN
Brett R. Larsen	Date:	~~November~~February 9, ~~2022~~2023
Executive Vice President of Administration, Chief Financial Officer and Treasurer
(Principal Financial Officer)